Tyler Dylan-Hyde, Chief Legal Officer at CRISPR Therapeutics AG (CRSP), sold 66,000 shares at $28.00 ($1.9M) on 2018-01-16, disclosed to the SEC on 2018-01-18.
Open-market sale of $1.9M CRSP by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 45,000 | $1.3M | 68.1% |
| 2 | $28.10 | 19,890 | $559K | 30.2% |
| 3 | $28.24 | 1,110 | $31K | 1.7% |
| Total | $28.03 avg | 66,000 | $1.9M | 100% |
| Filing → |
| CRSP | SELL | 2017-12-27 | $308K | — | Filing → |
| CRSP | SELL | 2017-12-19 | $284K | — | Filing → |
| CRSP | SELL | 2017-08-08 | $524K | — | Filing → |